Literature DB >> 11392879

Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus.

M Sarbia1, J Arjumand, M Wolter, G Reifenberger, H Heep, H E Gabbert.   

Abstract

Barrett esophagus (BE) is a condition in which the normal squamous epithelium of the esophagus is replaced by a metaplastic columnar epithelium. BE is a premalignant lesion that represents the initial step in a metaplasia-dysplasia-carcinoma sequence. In the present study, amplification of the proto-oncogene c-myc was determined by means of differential polymerase chain reaction analysis of metaplastic specialized epithelium, low-grade dysplasia, high-grade dysplasia, and invasive adenocarcinoma obtained by microscopic dissection of 43 esophagectomy specimens. Amplification of c-myc was found in none of 29 specialized epithelial specimens, none of 23 low-grade dysplasia specimens, 6 of 24 high-grade dysplasia specimens, and 17 of 39 adenocarcinoma specimens. Our data indicate that amplification of c-myc is a late event in the metaplasia-dysplasia-carcinoma sequence in BE. Furthermore, determination of c-myc amplification may help identify high-risk patients who would benefit from intensified endoscopic surveillance or from immediate treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11392879     DOI: 10.1309/MXXH-25N3-UAL2-G7XX

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Kevin C Halling; Navtej S Buttar; Louis-Michel Wongkeesong; Alan R Zinsmeister; Shannon M Brankley; Emily G Barr Fritcher; Wytske M Westra; Kausilia K Krishnadath; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

2.  c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Franziska Pühringer-Oppermann; Mario Sarbia
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

3.  The role of oncogenes in gastrointestinal cancer.

Authors:  Emmanouil P Pappou; Nita Ahuja
Journal:  Gastrointest Cancer Res       Date:  2010-11

4.  Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction.

Authors:  Franziska Pühringer-Oppermann; Michael Stahl; Gisela Keller; Mario Sarbia
Journal:  J Cancer Res Clin Oncol       Date:  2006-03-15       Impact factor: 4.553

5.  CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.

Authors:  Tuomo Rantanen; Tuuli Kauttu; Jonne Åkerla; Teemu Honkanen; Leena Krogerus; Jarmo Salo; Timo Paavonen; Niku Oksala
Journal:  Med Oncol       Date:  2013-08-08       Impact factor: 3.064

Review 6.  Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction.

Authors:  Nicholas J Clemons; Wayne A Phillips; Reginald V Lord
Journal:  Cancer Biol Ther       Date:  2013-06-17       Impact factor: 4.742

7.  Barrett's oesophagus and adenocarcinoma.

Authors:  Christine P J Caygill; Anthony Watson; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Surg Oncol       Date:  2004-05-07       Impact factor: 2.754

8.  Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.

Authors:  Chin-Ann Johnny Ong; Nicholas B Shannon; Caryn S Ross-Innes; Maria O'Donovan; Oscar M Rueda; De-En Hu; Mikko I Kettunen; Christina Elaine Walker; Ayesha Noorani; Richard H Hardwick; Carlos Caldas; Kevin Brindle; Rebecca C Fitzgerald
Journal:  J Natl Cancer Inst       Date:  2014-04-28       Impact factor: 13.506

9.  Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma.

Authors:  Jun Hong; Selma Maacha; Abbes Belkhiri
Journal:  Mol Oncol       Date:  2018-11-05       Impact factor: 6.603

10.  Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.

Authors:  Ti-Chun Chan; Yi-Ting Chen; Kien Thiam Tan; Chia-Ling Wu; Wen-Jeng Wu; Wei-Ming Li; Ju-Ming Wang; Yow-Ling Shiue; Chien-Feng Li
Journal:  Clin Transl Med       Date:  2021-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.